IHE research validates 168 annual hours of recaptured staff time

The independent proof of strategic value

Swedish municipalities face a critical situation: The need for health and social care is rising due to an ageing population, while staff recruitment becomes increasingly difficult. 

This independent research by the Swedish Institute for Health Economics (IHE) was conducted to quantify the value of introducing medicine robots to address these strategic challenges. This case study demonstrates how moving beyond the unit price and investing in Evondos is validated by independent research that confirms substantial recovery of staff resources, translating directly into long-term financial and operational value. This proves the strategic foresight of choosing the most reliable partner that can deliver verifiable outcomes.

The hidden cost of resource scarcity

The challenge: The growing staff crisis and increased needs

The core challenge identified by the IHE study is the lack of personnel to meet the growing need for care among older citizens. This systemic issue creates twin operational and human costs:

• Unmet care needs: The scarcity of personnel means valuable time cannot be dedicated to other essential visits and work tasks.
• Staff burnout: The pressure to provide increased care with limited staff contributes directly to high levels of stress and poor planning flexibility.

The municipalities involved in the study recognised that investing in welfare technology, specifically Evondos, was essential to freeing time and providing a sustainable, high-trust solution to this workforce crisis.

The goal: Strategic validation through independent metrics

The IHE study was commissioned to achieve a precise, data-driven validation of the time released by the medicine robots. The strategic metrics sought were:

• Quantifiable time savings: To determine the average number of minutes released per individual per day.
• Stress and flexibility benefits: To capture the qualitative impact on staff planning and wellbeing.
• Strategic alignment: To confirm that the investment could contribute to meeting the increasing challenges of care needs and staff shortages.

Evondos' comprehensive solution

Partnering for resource solutions

The study exclusively featured four Swedish municipalities that had already implemented the Evondos medicine robot. The core value proposition of the Evondos solution assessed by IHE was its ability to replace certain staff-assisted medication handovers, ensuring the time could be reinvested elsewhere.

Investment in a partner, not just a device: The success validated by the IHE research is founded on Evondos' best-in-class support, reliability, and full-service platform. The investment includes:

Dedicated customer success managers: Highly trained professionals (often with a care background) who ensure the smooth adoption of the technology, organisational process changes, and coaching best practices.

Unmatched reliability: Evondos’ operational experience and commitment to high standards (99% adherence) ensures staff can trust the technology, minimising the fear that technology brings more work.

Shifting workforce burden to technology

The study focused on measuring the impact of replacing manual handovers (averaging 2.93 per day) with robot assistance. This shift was fundamental to workforce empowerment by reducing low-value tasks and freeing up high-value professional capacity.

Quantified value: The measurable return on investment

Outcome-driven results

The IHE's findings provided powerful, independent confirmation of the strategic financial and operational value of the Evondos investment.

Workforce empowerment: Capacity creation

The operational efficiencies generated clear and measurable staff capacity returns:

• 22 hours per month recovered (full): On average, 45 minutes were freed up per day per individual, equating to 22 hours per month.
• 14 hours per month recovered (net): Even when conservatively counting only handovers that did not coincide with other scheduled visits, the solution freed up 28 minutes per day, or 14 hours per month. This equates to 168 hours of verifiable capacity per year per user.
• Reduced staff stress: Survey respondents reported that the medicine robot contributes to reducing personnel stress by enabling greater flexibility in planning.

Cost-conscious innovation: Long-term fiscal relief

The quantitative data provides an undeniable business case for strategic investment:

• Meeting staffing challenges: The freeing up of time directly addresses the central challenge of staff shortages and increased care needs, mitigating long-term operational risk.
• Strategic reallocation: The recovered minutes can be dedicated to other essential visits and work tasks, turning a fixed labour cost into flexible capacity.

Outcome-driven care: Stability and continuity

The ability to release time helps to improve overall care quality and strategic objectives:

• Enhanced care focus: By removing the time-consuming administrative burden of medication dispensing, staff can dedicate their finite hours to high-value, person-centric care, aligning with the national shift towards better and more continuous care.

Why the IHE validated investment over price

For the Swedish municipalities in the IHE study, the investment in Evondos was justified by independent, quantitative data: They purchased 168 verified hours of annual staff capacity per user, direct relief from planning stress, and a sustainable strategic solution to the nation's rising care needs.

Ready to see the Evondos impact for yourself? Speak to us today to find out how we can provide the long-term value and strategic partnership needed to future-proof your healthcare service.